Key result
In mouse models, first-phase ejection fraction (EF1) significantly decreased early in abdominal aortic banding (18.8% vs 24.3%) and HFpEF (19.1% vs 25.8%) compared to controls.
Why the study?
The interplay between systolic and diastolic dysfunction in HFpEF progression is unclear, prompting investigation of temporal changes in these relationships using first-phase ejection fraction.
Does first-phase ejection fraction (EF1) decrease earlier than conventional systolic and diastolic markers in mouse models of HFpEF and pressure overload?
Does first-phase ejection fraction (EF1) decrease earlier than conventional systolic and diastolic markers in mouse models of HFpEF and pressure overload?
First-phase ejection fraction (EF1) is a sensitive, early marker of systolic impairment that decreases before conventional markers in mouse models of HFpEF and pressure overload, paralleling early diastolic changes.
The interplay between systolic and diastolic dysfunction in heart failure with preserved ejection fraction (HFpEF) progression is unclear. First-phase ejection fraction (EF1), a sensitive marker of early systolic function, aids in assessing systolic-diastolic relationships in human hypertension and aortic stenosis. This study examines temporal changes in these relationships in mouse models of HFpEF and elevated afterload. Mouse models of abdominal aortic banding (AAB) and HFpEF (induced by hypertension and high fat feeding) underwent comprehensive serial echocardiography. In AAB, EF1 significantly decreased at week 1 post-surgery (18.8 ± 1.2 vs 24.3 ± 0.8%, p<0.001) compared to controls, with further reduction at week 3 (16.8 ± 0.6%) and week 6 (13.9 ± 0.9%, both p<0.001). EF, global longitudinal strain (GLS) and longitudinal strain rate (LSR) remained unchanged until week 3. Isovolumic relaxation time (IVRT) was the only abnormal index of diastolic function at week 1. In the HFpEF model, EF1 significantly decreased at week 2 (19.1 ± 1.1 vs 25.8 ± 1.0%, p<0.001) compared to controls, while EF, GLS, and LSR were unaltered. At week 3, EF1 decreased further (18.1 ± 0.7%) alongside a significant reduction in GLS (p<0.01), while EF and LSR remained unchanged. IVRT increased early in the HFpEF model, followed by later left atrial (LA) enlargement. EF1, an early marker of systolic impairment, decreases early in HFpEF and afterload-induced dysfunction, accompanied by IVRT prolongation. LA dilatation appears later. These findings highlight the interplay between systolic and diastolic dysfunction in HFpEF progression.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2026) studied Heart failure with preserved ejection fraction (HFpEF) and pressure overload. Abdominal aortic banding (AAB) or DOCA/salt with high fat diet (HFpEF model) vs. Sham surgery and chow diet was evaluated on First-phase ejection fraction (EF1) at week 1 in AAB model (p=<0.001). In mouse models, first-phase ejection fraction (EF1) significantly decreased early in abdominal aortic banding (18.8% vs 24.3%) and HFpEF (19.1% vs 25.8%) compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: